LAR inhibitory peptide promotes recovery of diaphragm function and multiple forms of respiratory neural circuit plasticity after cervical spinal cord injury

Chondroitin sulfate proteoglycans (CSPGs), up-regulated in and around the lesion after traumatic spinal cord injury (SCI), are key extracellular matrix inhibitory molecules that limit axon growth and consequent recovery of function. CSPG-mediated inhibition occurs via interactions with axonal recept...

Full description

Bibliographic Details
Main Authors: Lan Cheng, Armin Sami, Biswarup Ghosh, Mark W. Urban, Nicolette M. Heinsinger, Sophia S. Liang, George M. Smith, Megan C. Wright, Shuxin Li, Angelo C. Lepore
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Neurobiology of Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996120304289
_version_ 1831545509727174656
author Lan Cheng
Armin Sami
Biswarup Ghosh
Mark W. Urban
Nicolette M. Heinsinger
Sophia S. Liang
George M. Smith
Megan C. Wright
Shuxin Li
Angelo C. Lepore
author_facet Lan Cheng
Armin Sami
Biswarup Ghosh
Mark W. Urban
Nicolette M. Heinsinger
Sophia S. Liang
George M. Smith
Megan C. Wright
Shuxin Li
Angelo C. Lepore
author_sort Lan Cheng
collection DOAJ
description Chondroitin sulfate proteoglycans (CSPGs), up-regulated in and around the lesion after traumatic spinal cord injury (SCI), are key extracellular matrix inhibitory molecules that limit axon growth and consequent recovery of function. CSPG-mediated inhibition occurs via interactions with axonal receptors, including leukocyte common antigen- related (LAR) phosphatase. We tested the effects of a novel LAR inhibitory peptide in rats after hemisection at cervical level 2, a SCI model in which bulbospinal inspiratory neural circuitry originating in the medullary rostral ventral respiratory group (rVRG) becomes disconnected from phrenic motor neuron (PhMN) targets in cervical spinal cord, resulting in persistent partial-to-complete diaphragm paralysis. LAR peptide was delivered by a soaked gelfoam, which was placed directly over the injury site immediately after C2 hemisection and replaced at 1 week post-injury. Axotomized rVRG axons originating in ipsilateral medulla or spared rVRG fibers originating in contralateral medulla were separately assessed by anterograde tracing via AAV2-mCherry injection into rVRG. At 8 weeks post-hemisection, LAR peptide significantly improved ipsilateral hemidiaphragm function, as assessed in vivo with electromyography recordings. LAR peptide promoted robust regeneration of ipsilateral-originating rVRG axons into and through the lesion site and into intact caudal spinal cord to reach PhMNs located at C3-C5 levels. Furthermore, regenerating rVRG axons re-established putative monosynaptic connections with their PhMNs targets. In addition, LAR peptide stimulated robust sprouting of both modulatory serotonergic axons and contralateral-originating rVRG fibers within the PhMN pool ipsilateral/caudal to the hemisection. Our study demonstrates that targeting LAR-based axon growth inhibition promotes multiple forms of respiratory neural circuit plasticity and provides a new peptide-based therapeutic strategy to ameliorate the devastating respiratory consequences of SCI.
first_indexed 2024-12-17T01:27:02Z
format Article
id doaj.art-8f970bd3288448ba90f5bc173ddf07a0
institution Directory Open Access Journal
issn 1095-953X
language English
last_indexed 2024-12-17T01:27:02Z
publishDate 2021-01-01
publisher Elsevier
record_format Article
series Neurobiology of Disease
spelling doaj.art-8f970bd3288448ba90f5bc173ddf07a02022-12-21T22:08:39ZengElsevierNeurobiology of Disease1095-953X2021-01-01147105153LAR inhibitory peptide promotes recovery of diaphragm function and multiple forms of respiratory neural circuit plasticity after cervical spinal cord injuryLan Cheng0Armin Sami1Biswarup Ghosh2Mark W. Urban3Nicolette M. Heinsinger4Sophia S. Liang5George M. Smith6Megan C. Wright7Shuxin Li8Angelo C. Lepore9Department of Neuroscience, Vickie and Jack Farber Institute for Neuroscience, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA 19107, United States of AmericaDepartment of Neuroscience, Vickie and Jack Farber Institute for Neuroscience, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA 19107, United States of AmericaDepartment of Neuroscience, Vickie and Jack Farber Institute for Neuroscience, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA 19107, United States of AmericaDepartment of Neuroscience, Vickie and Jack Farber Institute for Neuroscience, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA 19107, United States of AmericaDepartment of Neuroscience, Vickie and Jack Farber Institute for Neuroscience, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA 19107, United States of AmericaDepartment of Neuroscience, Vickie and Jack Farber Institute for Neuroscience, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA 19107, United States of AmericaDepartment of Neuroscience, Shriners Hospitals for Pediatric Research Center, Temple University School of Medicine, 3500 North Broad Street, Philadelphia, PA 19140-5104, United States of AmericaDepartment of Biology, Arcadia University, Glenside, PA 19038, United States of AmericaDepartment of Anatomy and Cell Biology, Shriners Hospitals for Pediatric Research Center, Temple University School of Medicine, 3500 North Broad Street, Philadelphia, PA 19140-5104, United States of AmericaDepartment of Neuroscience, Vickie and Jack Farber Institute for Neuroscience, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA 19107, United States of America; Corresponding author at: Department of Neuroscience, Vickie and Jack Farber Institute for Neuroscience, Sidney Kimmel Medical College at Thomas Jefferson University, 233 South 10th Street, BLSB 245, Philadelphia, PA 19107, United States of America.Chondroitin sulfate proteoglycans (CSPGs), up-regulated in and around the lesion after traumatic spinal cord injury (SCI), are key extracellular matrix inhibitory molecules that limit axon growth and consequent recovery of function. CSPG-mediated inhibition occurs via interactions with axonal receptors, including leukocyte common antigen- related (LAR) phosphatase. We tested the effects of a novel LAR inhibitory peptide in rats after hemisection at cervical level 2, a SCI model in which bulbospinal inspiratory neural circuitry originating in the medullary rostral ventral respiratory group (rVRG) becomes disconnected from phrenic motor neuron (PhMN) targets in cervical spinal cord, resulting in persistent partial-to-complete diaphragm paralysis. LAR peptide was delivered by a soaked gelfoam, which was placed directly over the injury site immediately after C2 hemisection and replaced at 1 week post-injury. Axotomized rVRG axons originating in ipsilateral medulla or spared rVRG fibers originating in contralateral medulla were separately assessed by anterograde tracing via AAV2-mCherry injection into rVRG. At 8 weeks post-hemisection, LAR peptide significantly improved ipsilateral hemidiaphragm function, as assessed in vivo with electromyography recordings. LAR peptide promoted robust regeneration of ipsilateral-originating rVRG axons into and through the lesion site and into intact caudal spinal cord to reach PhMNs located at C3-C5 levels. Furthermore, regenerating rVRG axons re-established putative monosynaptic connections with their PhMNs targets. In addition, LAR peptide stimulated robust sprouting of both modulatory serotonergic axons and contralateral-originating rVRG fibers within the PhMN pool ipsilateral/caudal to the hemisection. Our study demonstrates that targeting LAR-based axon growth inhibition promotes multiple forms of respiratory neural circuit plasticity and provides a new peptide-based therapeutic strategy to ameliorate the devastating respiratory consequences of SCI.http://www.sciencedirect.com/science/article/pii/S0969996120304289CSPGECMLARSCIBreathingFunctional recovery
spellingShingle Lan Cheng
Armin Sami
Biswarup Ghosh
Mark W. Urban
Nicolette M. Heinsinger
Sophia S. Liang
George M. Smith
Megan C. Wright
Shuxin Li
Angelo C. Lepore
LAR inhibitory peptide promotes recovery of diaphragm function and multiple forms of respiratory neural circuit plasticity after cervical spinal cord injury
Neurobiology of Disease
CSPG
ECM
LAR
SCI
Breathing
Functional recovery
title LAR inhibitory peptide promotes recovery of diaphragm function and multiple forms of respiratory neural circuit plasticity after cervical spinal cord injury
title_full LAR inhibitory peptide promotes recovery of diaphragm function and multiple forms of respiratory neural circuit plasticity after cervical spinal cord injury
title_fullStr LAR inhibitory peptide promotes recovery of diaphragm function and multiple forms of respiratory neural circuit plasticity after cervical spinal cord injury
title_full_unstemmed LAR inhibitory peptide promotes recovery of diaphragm function and multiple forms of respiratory neural circuit plasticity after cervical spinal cord injury
title_short LAR inhibitory peptide promotes recovery of diaphragm function and multiple forms of respiratory neural circuit plasticity after cervical spinal cord injury
title_sort lar inhibitory peptide promotes recovery of diaphragm function and multiple forms of respiratory neural circuit plasticity after cervical spinal cord injury
topic CSPG
ECM
LAR
SCI
Breathing
Functional recovery
url http://www.sciencedirect.com/science/article/pii/S0969996120304289
work_keys_str_mv AT lancheng larinhibitorypeptidepromotesrecoveryofdiaphragmfunctionandmultipleformsofrespiratoryneuralcircuitplasticityaftercervicalspinalcordinjury
AT arminsami larinhibitorypeptidepromotesrecoveryofdiaphragmfunctionandmultipleformsofrespiratoryneuralcircuitplasticityaftercervicalspinalcordinjury
AT biswarupghosh larinhibitorypeptidepromotesrecoveryofdiaphragmfunctionandmultipleformsofrespiratoryneuralcircuitplasticityaftercervicalspinalcordinjury
AT markwurban larinhibitorypeptidepromotesrecoveryofdiaphragmfunctionandmultipleformsofrespiratoryneuralcircuitplasticityaftercervicalspinalcordinjury
AT nicolettemheinsinger larinhibitorypeptidepromotesrecoveryofdiaphragmfunctionandmultipleformsofrespiratoryneuralcircuitplasticityaftercervicalspinalcordinjury
AT sophiasliang larinhibitorypeptidepromotesrecoveryofdiaphragmfunctionandmultipleformsofrespiratoryneuralcircuitplasticityaftercervicalspinalcordinjury
AT georgemsmith larinhibitorypeptidepromotesrecoveryofdiaphragmfunctionandmultipleformsofrespiratoryneuralcircuitplasticityaftercervicalspinalcordinjury
AT megancwright larinhibitorypeptidepromotesrecoveryofdiaphragmfunctionandmultipleformsofrespiratoryneuralcircuitplasticityaftercervicalspinalcordinjury
AT shuxinli larinhibitorypeptidepromotesrecoveryofdiaphragmfunctionandmultipleformsofrespiratoryneuralcircuitplasticityaftercervicalspinalcordinjury
AT angeloclepore larinhibitorypeptidepromotesrecoveryofdiaphragmfunctionandmultipleformsofrespiratoryneuralcircuitplasticityaftercervicalspinalcordinjury